EFFECTOR Therapeutics to Participate in Upcoming Investor Conference

SOLANA BEACH, Calif. and REDWOOD CITY, Calif., April 09, 2024 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR), a leader in the development of selective translation regulator inhibitor

GlobeNewswireApr 9 08:00 ET

Analysts Offer Insights on Healthcare Companies: Marinus (MRNS), UniQure (QURE) and EFFECTOR Therapeutics (EFTR)

TipRanksApr 8 22:20 ET

12 Health Care Stocks Moving In Friday's Intraday Session

GainersCandel Therapeutics (NASDAQ:CADL) stock increased by 27.6% to $8.17 during Friday's regular session. The company's market cap stands at $239.6 million. Galectin Therapeutics (NASDAQ:GALT) share

BenzingaApr 5 12:31 ET

Analysts Offer Insights on Healthcare Companies: EFFECTOR Therapeutics (EFTR), Adagene (ADAG) and Aquestive Therapeutics (AQST)

TipRanksApr 5 06:30 ET

Trending Stocks Today: Candel Therapeutics Shoots up 121.64%

April 4th - US stocks trending in regular trading hours.Gainers: $Candel Therapeutics(CADL.US)$ shoots up 121.64% to $3.72 with a turnover of $214.01 million. $Allurion Technologies(ALUR.US)$ surges 9

moomoo NewsApr 4 14:00 ET

Top Midday Decliners

eFFECTOR Therapeutics (EFTR) Chief Executive Officer Steve Worland said there is no "obvious path forward to continue developing tomivosertib in frontline NSCLC" based on the data currently available

MT NewswiresApr 4 13:54 ET